top of page

Our Mission

We are entrusted with advancing the medical treatment of humankind. We accept this serious responsibility and will conduct ourselves with diligence and integrity. Always.

 

Initiative
We deliver high quality service by proactively anticipating challenges and introducing interventions where needed

 

Integration
Our project teams work collaboratively with our Clients, Investigators, and Vendors providing value in time, quality and cost

 

Integrity
We are a skilled group of committed, accountable and approachable professionals providing ethical and honest service

 

Intelligence
We combine cutting-edge science and technology with practical clinical operations and bring innovative ideas to cardiovascular, metabolic disease and dermatology research

 

Implementation
In adhering to these service commitments, our valued employees take pride in the efficient and expeditious execution of all project tasks from start to finish

 

 

Our Quick Turnaround

 

Accelerate Your Ambition TM

  • At Integrium, we understand the need for speed.

 

  • We know that you need answers. Quickly.

 

  • We can help you obtain the reliable, accurate data you need to make informed decisions, reach inflection points and make go or no-go decisions.

 

  • IntegriumQT is dedicated to delivering early phase results fast.

 

  • But we’re also proud of our proven track record of delivering results that are consistently accurate, reliable and communicated with clarity and precision.

 

Generally, in as few as 90 days, we can help you complete:

  • IND Creation

  • Recruiting/Enrollment

  • Protocol Development

  • Study Conduct

  • IRB Submission

  • Topline Results

 

IntegriumQT conducts Phase I/PK studies:

  • First-in-Human Studies

  • Indication-Specific

  • Pharmacokinetics / Pharmacodynamics

  • Proof of Concept

  • Single / Multiple Ascending Dose

  • Special Populations

  • Dose Ranging

  • Thorough QT/QTc

  • Maximum Tolerated Dose

  • Food Effect

  • Bioavailability / Bioequivalence

  • Drug-Drug Interaction

 

IntegriumQT accelerated Phase I studies feature:

  • Expert Study Design and Protocol Writing

  • Rapid Enrollment

  • Fully-Equipped 50-Bed Clinical Research Unit with:

    • Extensive Subject Database

    • ECG, ABPM, Holter Monitoring

    • Thorough QT/QTc, Telemetry

    • PK/PD

  • Medical Monitoring

  • Data Management and Biostatistics

  • Clinical Study Reports

     

     

     

     

     

     

     

     

     

  • RSS Social Icon
  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon

Join our mailing list

Never miss a beat

bottom of page